Please login to the form below

Not currently logged in
Email:
Password:

Drug prices

This page shows the latest Drug prices news and features for those working in and with pharma, biotech and healthcare.

AbbVie says Allergan takeover delayed by FTC verdict

AbbVie says Allergan takeover delayed by FTC verdict

AZ licensed the drug – which is in late-stage testing for ulcerative colitis and Crohn’s disease – to Allergan in 2016. ... They say the merger with Allergan to create the fourth-largest pharma company will increase the use of this strategy and

Latest news

More from news
Approximately 23 fully matching, plus 182 partially matching documents found.

Latest Intelligence

  • 20 for 2020 – Five pharma leaders to watch in 2020 20 for 2020 – Five pharma leaders to watch in 2020

    on 18 December 2019 to allow medicine imports from Canada to help tackle high drug prices. ... Dupixent for eczema and asthma – in order to ramp up internal generation of new drug candidates.

  • BRIC markets BRIC markets

    Drug reimbursement lists. All the BRIC nations have lists of medicines reimbursed at government level. ... US drug prices are often used as a direct or indirect reference for products sold in BRIC markets.

  • Will biosimilars ever catch on in the US? Will biosimilars ever catch on in the US?

    exclusivity ends. Thus in the US we see generic drug prices often reduced by as much as 90% or more, with uptake then rising accordingly. ... Sometimes prices fall so low manufacturers lose interest. For example, a shortage of the cancer drug

  • The Golden Goose The Golden Goose

    Why it’s so hard for the US to curb runaway drug prices. ... Hard to explain. Politically, reducing drug prices, or at least appearing to do so, has been at the forefront of the federal government’s goals for the past two years.

  • The fight for affordable insulin The fight for affordable insulin

    In April, in response to growing outrage over the problem (and the wider issue of rising drug prices), executives from pharma companies, pharmacy benefit managers (PBMs) and health insurers were hauled ... Recent weeks have seen President Trump shift his

More from intelligence
Approximately 2 fully matching, plus 31 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • The 'winner takes all' pricing game

    Other drivers of price erosion include high prices, high volumes, and tendering by 'winner takes all' where there are alternatives available. ... For the customer, tendering can be an efficient tool for lowering prices, but there are also challenges:.

  • Three strategies for managing loss of exclusivity successfully

    Patent losses could sink Allergan”. “Drug prices to plummet in wave of expiring patents”. ... patent cliff” is an ominous prospect for drug manufacturers – shrouded in the threat of job losses and falling share prices.

  • Oncology drugs under AMNOG

    Part 1: Segmentation and comparator choice - lessons for cancer drug market access in Germany. ... How to prepare. Germany is one of the largest pharmaceutical markets in Europe and drug prices there are used as reference prices in other markets.

More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cello Health

Cello Health are expert navigators, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices...

Latest intelligence

COVID-19 is redefining the value of ‘critical jobs’: An opportunity for social care?
...
How to keep your weight under control during lockdown
...
Brands stepping up to show solidarity during COVID-19
The brands that are stepping up to show solidarity during COVID-19 will be those that are remembered long after pandemic passes....

Infographics